Zhao et al. found that high CEAIn level (>10 ng/mL) was associated with poor PFS and OS in stage IIIB/IV NSCLC patients with EGFR-mutations, whereas the association between CEAIn level with survival in the EGFR-wild group was not addressed33. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.